Document is current
Any future updates will be listed below
-
Authors
Zheng, Jiajun
Wang, Zhi
Zhu, Huanfeng
Guo, Wenjie
Wu, Jianfeng
Sun, Li
Zong, Dan
He, Xia
-
Funding
Funding for this research was provided by:
National Key Research & Development Program of China (2022YFC2404605, 2022YFC2404605)
Spark Basic Research Program of Jiangsu Cancer Hospital (ZJ202309)
- License Information
-
More Information
Article History
Received: 23 May 2024
Accepted: 24 March 2025
First Online: 2 April 2025
Declarations
:
: This study was approved by the Ethics Committee of Jiangsu Cancer Hospital, Jiangsu Province, China (Ethic number: 2022-028) and was conducted in accordance with the Declaration of Helsinki. All patients provided verbal informed consent prior to inclusion in the study for the research use and publishing of their clinical data.
: No conflicts of interest.
: Not applicable.
